WebDec 3, 2024 · SAN DIEGO, CA – December 3, 2024 -- Neurelis, Inc. today announced the acquisition of Aegis Therapeutics, a San Diego-based drug delivery technology company. Aegis Therapeutics’ proprietary portfolio includes Intravail®, ProTek® and Hydrogel™, three non-invasive drug delivery and stabilization technologies applicable to a wide … WebJan 27, 2024 · CINCINNATI, OH—January 27, 2024 /PRNewswire/ – Enable Injections, Inc. (“Enable”), a company developing and manufacturing the enFuse® platform of investigational wearable drug delivery systems, is pleased to announce $215 million in Series C financing.
Enable Medicine Find new spatial biology insights
Web3/24. 37° Lo. RealFeel® 33°. Mostly cloudy. Wind NW 6 mph. Wind Gusts 13 mph. Probability of Precipitation 18%. Probability of Thunderstorms 1%. Precipitation 0.00 in. WebOur mission is to support and enable the creation of novel therapeutics for the treatment of cancer, autoimmune, and infectious disease by leveraging the human leukocyte antigen (HLA) system to selectively identify and … blank male reproductive system diagram
Enable Injections Enters into Strategic Partnership with Genentech, …
WebMay 26, 2024 · Enable Therapeutics. Jul 2024 - Jan 20242 years 7 months. • Led and executed all activities and strategy. • Awarded and … WebApr 20, 2024 · Enable Therapeutics has raised a total of $251K in funding over 1 round. This was a Grant round raised on Apr 20, 2024. Enable Therapeutics is funded by National Science Foundation. Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 1. Total Funding Amount $251K. WebEnable Injections develops and manufactures on-body delivery devices that allow patients to self-administer high-volume (up to 50 mL) and/or high-viscosity therapeutics. The company’s devices can be used to bring a new product to market, support lifecycle management (iv to sc; changes to dosing frequency), reduce overall healthcare costs ... blank login screen windows 10